StockData
Eikon Therapeutics, Inc. logo

Eikon Therapeutics, Inc. (EIKN) stock

EIKNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$5.17+0.02 (+0.39%)

Close on Nov 18, 2026Market cap $280.03MP/E –Yield –

Eikon Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Eikon Therapeutics's price to book ratio was 0.8× on Nov 11, 2026.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.8×–

More Eikon Therapeutics figures

See a number that looks wrong?